Manegold-Brauer G, Maymon R, Shor S, Cuckle H, Gembruch U, Geipel A. Down's syndrome screening at 11-14 weeks' gestation using prenasal thickness and nasal bone length.
Arch Gynecol Obstet 2019;
299:939-945. [PMID:
30739175 DOI:
10.1007/s00404-019-05083-2]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2018] [Accepted: 02/02/2019] [Indexed: 11/30/2022]
Abstract
PURPOSE
To perform a multicenter prospective study of ultrasound prenasal thickness (PT), and nasal bone length (NBL) measurement at 11-14 weeks' gestation.
METHODS
Ultrasound PT and NBL determination was performed in 504 normal fetuses and 17 fetuses with Down's syndrome (DS). Measurements were made from mid-sagittal 2D images acquired using a standardized technique during nuchal translucency (NT) examination. PT and NBL values were expressed in multiples of the gestation-specific normal median (MoM) and as the PT/NBL ratio. Information on PT and NBL MoMs was also combined using logistic regression. Results were classified as positive according to whether they were greater than the normal 95th centile for PT, PT/NBL and the DS risk from logistic regression equation or below the 5th centile for NBL.
RESULTS
The median value in DS cases and unaffected controls were: PT 1.26 and 0.996 MoM; and NBL 0.596 and 0.993 MoM. The proportion of DS fetuses with positive results was 41% for PT, 65% for NBL, and 82% for both the PT/NBL ratio and DS risk from the logistic regression equation. PT/NBL levels did not vary according to gestational age.
CONCLUSION
The PT/NBL ratio is a valuable first trimester DS screening marker that can be easily determined concomitant with the NT measurement.
Collapse